TNFSF9 and neoplasm: Interestingly, host-derived IL-12 did not appear to play a major role in the anti-tumor response to rIL-12 monotherapy (Figure S7H), but it was critical for the efficacy of Tnfsf9 monotherapy and the combination treatment.